Pentixapharm Ag
Clinical trials sponsored by Pentixapharm Ag, explained in plain language.
-
New imaging agent for lymphoma shows promise but trial stalls
Diagnosis TerminatedThis phase 3 trial tested a new radioactive imaging agent called [68Ga]Ga-PentixaFor to see if it could better detect lymphoma tumors compared to the standard PET scan. The study aimed to enroll adults with marginal zone lymphoma who had not yet been treated. However, the trial w…
Phase: PHASE3 • Sponsor: Pentixapharm AG • Aim: Diagnosis
Last updated Jun 27, 2026 12:25 UTC
-
New imaging test aims to predict chemotherapy outcomes in rare brain cancer
Diagnosis TerminatedThis study tested whether a special PET scan using a tracer called 68Ga-PentixaFor could predict how well patients with central nervous system lymphoma respond to chemotherapy. The plan was to scan patients before, during, and after treatment and see if the scan results matched t…
Phase: PHASE2 • Sponsor: Pentixapharm AG • Aim: Diagnosis
Last updated Jun 26, 2026 13:53 UTC